fbpx Skip to main content

BioCommunique Article

The program will continue to assist in bringing California’s life science industry back to the workplace safely and effectively.

Biocom Purchasing Group Partners with Everlywell to Offer At-Home COVID-19 Testing and Lens Reporting Technology to Biocom Members

  • 2020-10-29T19:00:00.000+0000
  • California
  • Author: Lauren Panetta

Biocom Purchasing Group is proud to announce a new program with Everlywell which will offer at-home sample collection COVID-19 test kits and reporting to all Biocom members who may need testing, regardless of company size.

Biocom’s program serves to extend effective, well-established and easy-to-perform self-collection nasal swab testing to over 1,300 members across the state under the Food and Drug Administration (FDA)’s Emergency Use Authorization (EUA) framework. Test purchases come equipped with Everlywell Lens, a comprehensive reporting dashboard for human resource representatives, which gives organizations visibility into the status of individual kits, from registration to results.

“Traditionally, this kind of testing solution is not accessible for companies with fewer than 500 employees,” said Rick Fultz, chief business officer of Biocom. “Everlywell testing kits will be instrumental in our members’ ability to get tested from the safety of their own home for COVID-19 and ensure secure digital results within 24-72 hours of the lab receiving their sample. We are eager for our members to begin taking advantage of this new partnership with one of the national leaders in at-home collection lab testing.”

The program with Everlywell, which launched this week, will provide Biocom members access to rt-PCR tests that will determine the presence or absence of RNA from the SARS-CoV-2-virus. Met with the highest standards of quality, safety, and reliability, Everlywell’s straightforward sample collection, free shipping, and physician-reviewed results and insights ensure that we are connecting our members with one of the best testing solutions in the market. The laboratories used by Everlywell are CLIA-certified and many are CAP-accredited, which means they must meet or exceed high precision, accuracy, and validity standards, obtain both state and federal certifications, and submit themselves to regular inspections as well as independent third-party performance verifications.

To learn more about the program or to request an order of Covid-19 test kits, please visit our Biocom + Everlywell program page.